# US 2026/0263548 A1 · Gastrointestinal health supplements

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0263548 A1
- Document ID: US20260263548A1
- Status: Published application
- Kind: A1
- Application number: 19/166,233
- Filed: 2024-03-18
- Published: 2026-09-10
- Earliest claimed: 2023-03-17
- Assignees: Bimini LLC
- Applicants: Bimini, LLC
- Inventors: Samer AL-MURRANI
- Web page: https://patentgrep.com/patent/US20260263548A1

## CPC

- A61K 36/73: Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K 36/81: Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K 9/0056: {Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals}
- A61K 9/1623: {Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules}
- A61K 35/16: Blood plasma; Blood serum (umbilical cord blood A61K35/51)
- A61K 35/20: Milk; Whey; Colostrum
- A61K 35/57: Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
- A61K 35/60: Fish, e.g. seahorses; Fish eggs
- A61K 35/612: Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
- A61K 35/744: Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K 35/747: Lactobacilli, e.g. L. acidophilus or L. brevis
- A61K 36/16: Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
- A61K 36/185: Magnoliopsida (dicotyledons)
- A61K 36/258: Panax (ginseng)
- A61K 36/28: Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K 36/42: Cucurbitaceae (Cucumber family)
- A61K 36/48: Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K 36/484: Glycyrrhiza (licorice)
- A61K 36/505: Corydalis
- A61K 36/76: Salicaceae (Willow family), e.g. poplar
- A61K 36/9066: Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
- A61K 36/9068: Zingiber, e.g. garden ginger
- A61K 38/4873: {Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H}
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- C12Y 304/22002: Papain (3.4.22.2)
- C12Y 304/22004: Bromelain (3.4.22.4) (C12Y304/22032, C12Y304/22033 take precedence)
- A61K 2035/115: {Probiotics}
- A61K 2300/00: Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12Y: ENZYMES

## Abstract

Multi-action dosage form health supplements for supporting animal health and well-being, in particular through supporting digestive health. The formulations comprise blends of active anti-inflammatory botanical/herbal agents and/or probiotics, preferably two or more species-specific probiotics and/or antibodies, such as IgY and/or IgG derived from eggs, colostrum, and/or serum. Methods of supporting digestive health.

## Claims

### Claim 1

A composition for supporting and maintaining a healthy digestive tract in a subject, the composition comprising a blend of an active agent formulation and a base formulation, wherein the active agent formulation comprises:
at least one, preferably two or more, anti-inflammatory botanical agent and/or oil, selected from the group consisting Agrimony, Cramp Bark, Golden seal, Marshmallow (plant), Meadowsweet, Ashwagandha, Chasteberry, Ginkgo Biloba, Siberian Ginseng, Skullcap, St. John's Wort, Corydalis, Devil's Claw, Willow Bark, Burdock, Cleavers, Echinacea, Licorice, Turmeric, Nettle Leaf, Red Clover, pumpkin seed powder, ginger root powder, chamomile flower powder, passionflower powder, salmon oil, primrose oil, sunflower oil, and/or krill oil;
at least one enzyme selected from the group consisting of proteolytic enzymes, amylases, and lipases; and
at least one probiotic or probiotic blend.

### Claim 2 (depends on 1)

The composition of claim 1, wherein said probiotic or probiotic blend is a species-specific spore-forming or non-spore forming probiotic, specific for the species of the subject.

### Claim 3 (depends on 1)

The composition of claim 1, wherein said active agent formulation further comprises chicken egg powder.

### Claim 4 (depends on 1)

The composition of claim 1, wherein said probiotic or probiotic blend comprises one or more of Enterococcus faecium, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus lactis, and Lactobacillus reuteri.

### Claim 5 (depends on 1)

The composition of claim 1, wherein said enzyme is Papain and/or Bromelain.

### Claim 6 (depends on 1)

The composition of claim 1, wherein the active formulation comprises a blend of at least five different anti-inflammatory botanical agents and/or oils.

### Claim 7

A composition for supporting and maintaining a healthy digestive tract in a subject, the composition comprising a blend of an active agent formulation and a base formulation, wherein the active agent formulation comprises:
one or more species-specific spore-forming or non-spore forming probiotic, specific for the species of the subject; and
one or more species-specific antibody from immunized or pre-immunized chicken egg powder, immunized or pre-immunized colostrum, and/or immunized or pre-immunized serum from a donor animal of the same species as the subject.

### Claim 8

(canceled)

### Claim 9 (depends on 7)

The composition of claim 7, wherein the active formulation comprises about 0.01 Billion colony forming units (cfu) to about 20 Billion cfu of the one or more species-specific spore-forming or non-spore forming probiotics selected from a group consisting of Bifidobacterium, Enterococcus, Lactobacillus, Bacillus, Pediococcus, Limosilactobacillus, Lacticaseibacillus, and Levilactobacillus.

### Claim 10 (depends on 7)

The composition of claim 7, wherein the active formulation comprises from about 0.25 to about 75% by weight of a blend of immunized or pre-immune egg powder as a source of IgY antibodies and early milk colostrum as a source of IgG and other immune molecules.

### Claim 11 (depends on 7)

The composition of claim 7, wherein the active formulation further comprises a source of fiber selected from one or more of the following: pumpkin seed powder, glucomannan, inulin, maltodextrin, pectin, oat bran, or rice bran.

### Claim 12 (depends on 7)

The composition of claim 7, wherein the active formulation further comprises at least one, preferably two or more, anti-inflammatory botanical agent and/or oil, selected from the group consisting Agrimony, Cramp Bark, Golden seal, Marshmallow (plant), Meadowsweet, Ashwagandha, Chasteberry, Ginkgo Biloba, Siberian Ginseng, Skullcap, St. John's Wort, Corydalis, Devil's Claw, Willow Bark, Burdock, Cleavers, Echinacea, Licorice, Turmeric, Nettle Leaf, Red Clover, pumpkin seed powder, ginger root powder, chamomile flower powder, passionflower powder, salmon oil, primrose oil, sunflower oil, and/or krill oil.

### Claim 13 (depends on 7)

The composition of claim 7, wherein the active formulation further comprises at least one enzyme selected from the group consisting of proteases, cellulases, amylases, lipases, and mixtures thereof.

### Claim 14 (depends on 1)

A dosage form comprising or consisting of a composition according to claim 1, said dosage form being selected from the group consisting of powders, chews, tablets, gummies, oils, and liquids.

### Claim 15 (depends on 14)

The dosage form of claim 14, wherein said dosage form is a soft chew, wherein said soft chew has a water activity level of less than 0.75.

### Claim 16 (depends on 14)

The dosage form of claim 14, wherein said composition is essentially free of added water.

### Claim 17 (depends on 1)

A method for supporting and maintaining a healthy digestive tract in a subject, the method comprising administering an effective amount of a composition according to claim 1 or a dosage form thereof to a subject in need thereof.

### Claim 18 (depends on 17)

The method of claim 17, wherein said composition enhances or supports remote health effects in said subject beyond the gastrointestinal tract due to absorption of metabolites produced by the probiotics in the gastrointestinal tract of the subject.

### Claim 19 (depends on 17)

The method of claim 17, wherein said administering step comprises placing said composition or dosage form in a location where the subject will come into contact with and ingest the composition or dosage form.

### Claim 20

(canceled)

### Claim 21

A composition for supporting and maintaining a healthy digestive tract in a subject, the composition comprising a blend of an active agent formulation and a base formulation, wherein the active agent formulation comprises one or more biologically active proteins selected from lactoferrin, lactoperoxidase, lysozyme, alpha-lactalbumin, beta-lactoglobulin, glycomacropeptide and ovotransferrin.

### Claim 22 (depends on 21)

The composition of claim 21, wherein said active formulation comprises colostrum as a source of said lysozyme and/or egg powder as a source of said ovotransferrin.

### Claim 23 (depends on 21)

The composition of claim 21, comprising two or more of said biologically active proteins.

### Claim 24 (depends on 21)

The composition of claim 21, wherein the active formulation further comprises one or more species-specific spore-forming or non-spore forming probiotics selected from a group consisting of Bifidobacterium, Enterococcus, Lactobacillus, Bacillus, Saccharomyces, Pediococcus, Limosilactobacillus, Lacticaseibacillus, and Levilactobacillus.
